Mylan Laboratories Limited Gliclazide Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Gliclazide Export Records India — #1 Exporter, 133 Shipments, $6.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Gliclazide

India Pharmaceutical Trade Intelligence

$300.8M238 Suppliers109 CountriesHS 30049099

ExportsIndia → HUNGARY29.3%India → NETHERLANDS29.2%

ImportsUNITED KINGDOM → India$1.0M BULGARIA → India$261.6K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN HUNGARY

Mylan Laboratories Limited — Gliclazide Exporter #1 | $6.7M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Gliclazide Exporter Profile

Indian Pharmaceutical Exporter · #1 for Gliclazide · $6.7M export value · DGFT Verified

Mylan Laboratories Limited is the #1 Indian exporter of Gliclazide with $6.7M in export value and 133 verified shipments. Mylan Laboratories Limited holds a 3.5% market share in Gliclazide exports across 7 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Gliclazide Export Profile: Buyers & Destinations

Mylan Laboratories Limited Gliclazide export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Laboratories Limited Export Gliclazide?

Country	Value	Shipments	Share
HUNGARY	$1.7M	43	40.3%
NETHERLANDS	$895.9K	26	21.2%
FRANCE	$895.1K	36	21.2%
SOUTH AFRICA	$344.4K	14	8.1%
CANADA

Who Are the Top Buyers of Gliclazide from Mylan Laboratories Limited?

Buyer	Country	Value	Orders
MYLAN HUNGARY KFT,	HUNGARY	$878.4K	21
MYLAN HUNGARY KFT	HUNGARY	$585.1K	17
MYLAN B V	NETHERLANDS	$308.4K	9
CSP VIATRIS SANTE AT CSP- LABO,	FRANCE	$297.6K	8
CSP VIATRIS SANT? AT CSP- LAB,	FRANCE	$280.0K	12
MYLAN HUNGARY KFT MYLAN U	HUNGARY	$150.0K	3
MYLAN B V C	NETHERLANDS	$144.5K	3
CSP	FRANCE	$123.9K	3
CSP VIATRIS SANTE AT CSP- LAB,	FRANCE	$106.1K	6
MYLAN B.V.	NETHERLANDS	$100.2K	3

Mylan Laboratories Limited supplies Gliclazide to 33 buyers globally. The largest buyer is MYLAN HUNGARY KFT, (HUNGARY), followed by MYLAN HUNGARY KFT (HUNGARY) and MYLAN B V (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Gliclazide Formulations Does Mylan Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
GLICLAZIDE MODIFIED RELEASE TABLETS 30 M	$595.6K	13
GLICLAZIDE TAB PR 30MG EU (PACKS: 5000'S BSP)	$150.0K	3
GLICLAZIDE TABLETS 80 MG PACKS 4000SBSP	$144.5K	3
HARMLESS MEDICINES, GLICLAZIDE TAB PR 30MG EU	$113.0K	3
GLICLAZIDE TAB PR 30MG 180BT NL MY PACKS47732	$100.2K	3
HARMLESS MEDICINES, GLICLAZIDE MODIFIED	$100.0K	2
GLICLAZIDE RETARD MYLAN 30 MG 180BT 281	$100.0K	2
GLICLAZIDE TAB PR 60MG 30BT ZA MY PACKS50326	$100.0K	2
GLICLAZIDE MODIFIED RELEASE TABLETS 30 MG PACKS 5000S BSP	$100.0K	2
GLICLAZIDE TABLETS 80 MG (PACKS 4000SBSP)	$100.0K	2

Mylan Laboratories Limited exports 74 distinct Gliclazide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is GLICLAZIDE MODIFIED RELEASE TABLETS 30 M with 13 shipments worth $595.6K.

How Does Mylan Laboratories Limited Compare to Nearest Gliclazide Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	MICRO LABS LIMITED	$7.6M	205	17	$37.2K
5	IPCA LABORATORIES LIMITED	$7.3M	243	18	$30.2K
1	MYLAN LABORATORIES LIMITED ★	$6.7M	133	7	$50.0K
6	TORRENT PHARMACEUTICALS LTD	$6.1M	217	3	$28.1K
7	LUPIN LIMITED	$4.9M	145	8	$33.6K

Mylan Laboratories Limited ranks #1 among 238 Indian Gliclazide exporters. Average shipment value of $50.0K compared to the market average of $287.6K. The closest competitors by value are MICRO LABS LIMITED and IPCA LABORATORIES LIMITED.

Which Indian Ports Ship Gliclazide Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	439	11.5%
SAHAR AIR	375	9.8%
JNPT/ NHAVA SHEVA SEA	323	8.4%
SAHAR AIR CARGO ACC (INBOM4)	247	6.4%
DELHI AIR	229	6.0%
JNPT	203	5.3%
DELHI AIR CARGO ACC (INDEL4)	165	4.3%
CMA CGM LOGISTICS PARK ICD	103	2.7%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Gliclazide Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Gliclazide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 133 individual customs records matching Mylan Laboratories Limited exporting Gliclazide, covering 74 formulations to 7 countries via 33 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 109+ countries, 643+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Gliclazide

Gliclazide

Mylan Laboratories Limited — Gliclazide Exporter Profile

Mylan Laboratories Limited — Gliclazide Export Profile: Buyers & Destinations

Where Does Mylan Laboratories Limited Export Gliclazide?

Who Are the Top Buyers of Gliclazide from Mylan Laboratories Limited?

What Is India's Total Gliclazide Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Gliclazide Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Gliclazide Exporters?

What Gliclazide Formulations Does Mylan Laboratories Limited Export?

How Does Mylan Laboratories Limited Compare to Nearest Gliclazide Exporters?

Which Indian Ports Ship Gliclazide Exports?

Gliclazide — Export Intelligence Video

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Gliclazide Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Gliclazide Export Data from Mylan Laboratories Limited

Gliclazide Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source